Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · Real-Time Price · USD
2.760
-0.060 (-2.13%)
Nov 20, 2024, 4:00 PM EST - Market closed
Aileron Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 60 | 15 | 11 | 51 | 42 | 16 | |
| Market Cap Growth | 1011.14% | 38.39% | -78.89% | 20.49% | 165.52% | 28.63% | |
| Enterprise Value | 87 | 3 | -15 | -1 | 33 | -3 | |
| Last Close Price | 2.76 | 3.05 | 2.37 | 11.26 | 20.80 | 11.46 | |
| PB Ratio | 1.19 | 0.15 | 0.58 | 1.16 | 3.48 | 0.99 | |
| P/TBV Ratio | - | - | 0.58 | 1.16 | 3.48 | 0.99 | |
| Debt / Equity Ratio | - | 0.00 | 0.00 | 0.00 | 0.03 | 0.31 | |
| Quick Ratio | 3.12 | 3.95 | 6.28 | 10.19 | 3.49 | 3.13 | |
| Current Ratio | 3.30 | 4.17 | 6.46 | 10.69 | 4.12 | 3.35 | |
| Return on Equity (ROE) | -54.95% | -26.91% | -87.42% | -93.33% | -150.00% | -164.77% | |
| Return on Assets (ROA) | -31.63% | -14.99% | -49.03% | -51.30% | -59.84% | -65.94% | |
| Return on Capital (ROIC) | -34.78% | -16.40% | -55.10% | -58.74% | -76.18% | -92.05% | |
| Earnings Yield | -48.90% | -105.62% | -253.93% | -51.32% | -50.00% | -184.30% | |
| FCF Yield | -46.61% | -132.99% | -231.03% | -46.90% | -48.40% | -167.08% | |
| Buyback Yield / Dilution | -201.87% | -1.31% | -2.23% | -154.70% | -42.11% | -66.48% | |
| Total Shareholder Return | -201.87% | -1.31% | -2.23% | -154.70% | -42.11% | -66.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.